Expression and Clinical Significance of Myeloid Derived Suppressor Cells in Chronic Hepatitis B Patients |
Lu, Li-Rong
(Department of Infectious Disease, The Third Affiliated Hospital of Sun Yat-sen University)
Liu, Jing (Department of Infectious Disease, The Third Affiliated Hospital of Sun Yat-sen University) Xu, Zhen (Department of Infectious Disease, The Third Affiliated Hospital of Sun Yat-sen University) Zhang, Geng-Lin (Department of Infectious Disease, The Third Affiliated Hospital of Sun Yat-sen University) Li, De-Chang (Department of Infectious Diseases, The Second People's Hospital of North Guangdong) Lin, Chao-Shuang (Department of Infectious Disease, The Third Affiliated Hospital of Sun Yat-sen University) |
1 | Tacke RS, Lee HC, Goh C, et al (2012). Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production ofreactive oxygenspecies. Hepatology, 55, 343-53. DOI ScienceOn |
2 | Revill P, Yuen L, Walsh R, et a1 (2010). Bioinformatic analysis of the hepadnavirus e-antigen and its precursor identifies remarkable sequence conservation in all orthohepadnaviruses. J Med Virol, 82, 104-15. DOI ScienceOn |
3 | Serafini P, Borrello I, Bronte V, et al (2006). Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol, 16, 53-65. DOI ScienceOn |
4 | Suzuki E, Kapoor V, Jassar AS, et al (2005). Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin Cancer Res, 11, 6713-21. DOI ScienceOn |
5 | Ito K, Kim KH, Lok AS, et aL (2009). Characterization ofgenotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigenprecursor and identification offurin as the candidate enzyme. J Virol, 83, 3507-17. DOI ScienceOn |
6 | Lathers DM, Clark JI, Achille NJ, et al (2004). Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3. Cancer Immunol Immunother, 53, 422-30. DOI |
7 | Lim YS, Han S, Heo NY, et al (2014). Liver Transplantation, and Hepatocellular Carcinoma Among Patients with Chronic Hepatitis B Treated with Entecavir vs Lamivudine. Gastroenterol, 25. |
8 | Martin F, Apetoh L, Ghiringhelli F (2012). Role of myeloidderived suppressor cells in tumor immunotherapy. Immunotherapy, 4, 43-57. DOI ScienceOn |
9 | Milich D, Liang TJ (2003). Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology, 38, 1075-86. DOI ScienceOn |
10 | Peranzoni E, Zilio S, Marigo I, et al (2010). Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol, 22, 238-44. DOI ScienceOn |
11 | Qin A, Cai W, Pan T, et al (2013). Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositiveindividuals. J Virol, 87, 1477-90. DOI |
12 | Bunt SK, Sinha P, Clements VK, et al (2006). Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J Immunol, 176, 284-90. DOI |
13 | Cai W, Qin A, Guo P, et al (2013). Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients. J Clin Immunol, 33, 798-808. DOI ScienceOn |
14 | Yu M, Niu ZM, Wei YQ (2013). Effective response of the peritoneum microenvironment to peritoneal and systemic metastasis from colorectal carcinoma. Asian Pac J Cancer Prev, 14, 7289-94. 과학기술학회마을 DOI ScienceOn |
15 | Tinoco R, Alcalde V, Yang Y, et a1 (2009). Cell-intrinsic transforming growth factor-beta signaling mediates virusspecific CD8+T cell deletion and viral persistence in vivo. Immunity, 31, 145-57. DOI ScienceOn |
16 | Vollbrecht T, Stirner R, Tufman A, et al (2012). Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS, 26, 31-7. DOI |
17 | Wang FS, Zhang Z (2009). Host immunity influences disease progression and antiviral efficacy in humansinfected with hepatitis B virus. Expert Rev Gastroenterol Hepatol, 3, 499-512. DOI ScienceOn |
18 | European Association for the Study of the Liver (2012). EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatology, 57, 167-85. DOI ScienceOn |
19 | Crawford A, Wherry EJ (2009). The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses. Curr Opin Immunol, 21, 179-86. DOI ScienceOn |
20 | Dmitry I, Gabrilovich, Srinivas Nagaraj (2009). Myeloidderived-suppressor cells as regulators of the immune system. Nat Rev Immunol, 9, 162-74. DOI ScienceOn |
21 | Gabrilovieh DI, Nagaraj S (2009). Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol, 9, 162-74. DOI ScienceOn |
22 | Greten TF, Manns MP, Korangy F,et al (2011). Myeloid derived suppressor cells in human diseases. Int Immunopharmacol, 11, 802-7. DOI ScienceOn |
23 | Hakan A, Ozturk O, Binnur K, et al (2013). Prevalence of common YMDD motif mutations in long term treated chronic HBV infections in a Turkish population. Asian Pac J Cancer Prev, 14, 5489-94. 과학기술학회마을 DOI ScienceOn |
24 | Li L, Wu B, Yang LB, et al (2013). Chronic hepatitis b virus infection and risk of pancreatic cancer: a meta-analysis. Asian Pac J Cancer Prev, 14, 275-9. 과학기술학회마을 DOI ScienceOn |
25 | Qu P, Boelte KC, Lin PC (2012). Negative regulation of myeloid-derived suppressor cells in cancer. Immunol Invest, 41, 562-80. DOI ScienceOn |